Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Erectile Dysfunction

Interventions

BIOLOGICAL

Cellgram-ED

Patients will receive single injection of Cellgram-ED(mesenchymal stem cell) intracavernously.

Trial Locations (4)

RECRUITING

Asan medical center, Seoul

RECRUITING

Ewha womans university medical center, Seoul

RECRUITING

Samsung medical center, Seoul

RECRUITING

Seoul ST. Mary's hospital, Seoul

All Listed Sponsors

lead

Pharmicell Co., Ltd.

INDUSTRY